Literature DB >> 23734366

Global Vaccine Action Plan. Decade of vaccine collaboration.

.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23734366     DOI： 10.1016/j.vaccine.2013.02.015

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  34 in total

1.  Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

Authors:  Nancy J Cox; Julian Hickling; Rebecca Jones; Guus F Rimmelzwaan; Linda C Lambert; John Boslego; Larisa Rudenko; Leena Yeolekar; James S Robertson; Joachim Hombach; Justin R Ortiz
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

Review 2.  New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening.

Authors:  Susan A Wang; Terri B Hyde; Sandra Mounier-Jack; Logan Brenzel; Michael Favin; W Scott Gordon; Jessica C Shearer; Carsten F Mantel; Narendra Arora; David Durrheim
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

3.  A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.

Authors:  Jessica C Joyce; Timothy D Carroll; Marcus L Collins; Min-Hsin Chen; Linda Fritts; Joseph C Dutra; Tracy L Rourke; James L Goodson; Michael B McChesney; Mark R Prausnitz; Paul A Rota
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

4.  A microneedle patch containing measles vaccine is immunogenic in non-human primates.

Authors:  Chris Edens; Marcus L Collins; James L Goodson; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2015-03-12       Impact factor: 3.641

5.  Both Sphingomyelin and Cholesterol in the Host Cell Membrane Are Essential for Rubella Virus Entry.

Authors:  Noriyuki Otsuki; Masafumi Sakata; Kyoko Saito; Kiyoko Okamoto; Yoshio Mori; Kentaro Hanada; Makoto Takeda
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

6.  Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016.

Authors:  Gavin B Grant; Balcha G Masresha; William J Moss; Mick N Mulders; Paul A Rota; Saad B Omer; Abigail Shefer; Jennifer L Kriss; Matt Hanson; David N Durrheim; Robert Linkins; James L Goodson
Journal:  Vaccine       Date:  2019-03-20       Impact factor: 3.641

Review 7.  Rubella.

Authors:  Nathaniel Lambert; Peter Strebel; Walter Orenstein; Joseph Icenogle; Gregory A Poland
Journal:  Lancet       Date:  2015-01-08       Impact factor: 79.321

8.  Measles: A Canary in the Coal Mines?

Authors:  Jacob John
Journal:  Indian J Pediatr       Date:  2016-01-26       Impact factor: 5.319

9.  Evolutionary genetics of genotype H1 measles viruses in China from 1993 to 2012.

Authors:  Songtao Xu; Yan Zhang; Pierre Rivailler; Huiling Wang; Yixin Ji; Zhu Zhen; Naiying Mao; Chongshan Li; William J Bellini; Wenbo Xu; Paul A Rota
Journal:  J Gen Virol       Date:  2014-06-09       Impact factor: 3.891

10.  The Mobile Solutions for Immunization (M-SIMU) Trial: A Protocol for a Cluster Randomized Controlled Trial That Assesses the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya.

Authors:  Dustin G Gibson; E Wangeci Kagucia; Benard Ochieng; Nisha Hariharan; David Obor; Lawrence H Moulton; Peter J Winch; Orin S Levine; Frank Odhiambo; Katherine L O'Brien; Daniel R Feikin
Journal:  JMIR Res Protoc       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.